Clean water drive rolled out in capital villages
The Islamabad Capital Territory (ICT) Administration has launched a clean drinking water initiative in rural parts of the capital, with the installation of three new solar-powered water filtration plants. The project aims to curb the spread of water-borne diseases in communities that previously lacked access to safe water.
One of the filtration plants was inaugurated in Sangjhani by the Additional Deputy Commissioner (East), Islamabad, along with the Country Representative of the World Health Organization (WHO) Pakistan. This plant is among three facilities set up under a collaborative effort by the DC Office, WHO, and the Government of Canada.
The newly installed filtration system in Sangjhani will serve over 23,000 people, including local residents and Afghan refugees. Powered by solar energy, the plant ensures uninterrupted access to filtered water in areas with unstable electricity supply, while also promoting environmental sustainability and reducing operational costs.
The filtration plants are designed to operate daily, allowing residents to collect clean water throughout the day. These facilities are a major step forward for remote communities that have long relied on contaminated sources, resulting in high rates of water-related illnesses.
Officials at the inauguration highlighted the critical link between clean water and public health, emphasizing that improving water quality is essential for disease prevention, particularly among children who are most vulnerable to unsafe water.
Residents welcomed the development, expressing hope that the new infrastructure would improve health outcomes and ease daily hardships. The DC Office affirmed its commitment to expanding such efforts across other underserved areas of Islamabad as part of a broader strategy to enhance rural infrastructure and living standards.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
12 hours ago
- Business Recorder
Pakistan's vaccine independence: a national imperative
Pakistan stands at a critical crossroads in public health policy. With seven million births annually and a population growth rate of 2.55%, our nation faces an unprecedented challenge in vaccine security that demands immediate and decisive action. The looming withdrawal of GAVI support by 2031 presents not just a crisis, but an opportunity to transform Pakistan into a self-reliant pharmaceutical powerhouse. The stark reality we face The numbers paint a sobering picture of our current vulnerability. Pakistan's complete dependency on donated and discounted vaccine supplies, supported by GAVI, UNICEF, and WHO to the tune of PKR 26 billion annually, masks a deeper structural weakness. When GAVI's support ends in 2031, the financial burden will balloon to PKR 100 billion annually as nearly four times our current federal health budget of PKR 27 billion. This dependency is not merely financial; it represents a fundamental threat to national health security. This isn't just underdevelopment—it's a systematic surrender of national health autonomy. Today, Pakistan produces virtually no antigens for the Expanded Programme on Immunization (EPI) vaccines domestically. We lack essential seed banks, have minimal university-based vaccine development programs, and operate with regulatory guidelines that are inadequate for sophisticated vaccine manufacturing. Our clinical trial expertise remains severely limited, creating bottlenecks in bringing locally developed vaccines to market. The contrast with global pharmaceutical leaders is stark. While universities worldwide have been the birthplace of revolutionary vaccines-from the Hepatitis B vaccine developed at UC San Francisco to the Oxford-AstraZeneca Covid-19 vaccine-Pakistan's academic institutions remain largely disconnected from commercial vaccine production. Learning from global success stories International experience offers valuable lessons. India transformed itself into the 'pharmacy of the world' through strategic government support for generic manufacturing and robust regulatory frameworks. Singapore built a biomedical hub through integrated research, manufacturing, and regulatory excellence that attracted billions in global pharmaceutical investment. South Korea's government-industry partnerships created world-class biopharmaceutical capabilities. These success stories share common elements: sustained government commitment, strategic investment in infrastructure, regulatory excellence, and comprehensive talent development programs. Most importantly, they demonstrate that with the right approach, developing nations can achieve pharmaceutical self-sufficiency and even become global exporters. The Triple Helix solution The path forward requires unprecedented coordination between government, academia, and industry -what experts call the 'Triple Helix' approach. Each sector must play a distinct yet interconnected role in building national vaccine capacity. Government leadership is essential in creating policy frameworks that incentivize domestic production while providing funding for university research. Strategic assignments to national research institutions like the National Institute of Health, Centre of Excellence in Molecular Biology (CEMB), National Institute for Biotechnology and Genetic Engineering (NIBGE), International Centre for Chemical and Biological sciences (ICCBS), Karachi University, Department of Biotechnology, Dow University of Health Sciences (DUHS), etc., can accelerate vaccine development and establish crucial seed banks. Most critically, the government must develop a comprehensive national health security strategy that positions vaccine self-sufficiency as a matter of national defense. The regulatory transformation cannot be understated. Pakistan's Drug Regulatory Authority must achieve WHO Level 3 qualification and create 'regulatory sandboxes — collaborative environments where university researchers, industry partners, and regulatory experts jointly develop guidelines for the 13 critical EPI vaccine antigens. Fast-track approval pathways and clear regulatory roadmaps will accelerate the journey from laboratory research to commercial production. Formation of sandboxes by bringing together leaders of the University, Regulatory and Industry. Universities must step up as innovation engines. Institutions with BSL-III laboratories should lead development of live attenuated vaccines, while biotechnology departments focus on recombinant vaccine technologies. Specialized vaccine research centers, industry-relevant curricula, and technology transfer offices will bridge the gap between academic discovery and commercial application. State-of-the-art pilot manufacturing facilities will provide proof-of-concept capabilities essential for scaling innovations. Industry brings manufacturing excellence and market expertise to the equation. Private sector partners can transform academic research into GMP-compliant commercial production, establish robust supply chains for raw materials, and navigate complex regulatory approvals. Their distribution networks and market access capabilities will ensure that domestically produced vaccines reach every corner of Pakistan. Leading companies in Pakistan already in the field of Biopharmaceutical manufacturing must be involved in the development process. A realistic implementation roadmap Success requires a phased approach spanning six years. The foundation phase (Years 1-2) must establish policy frameworks and coordination mechanisms while launching capacity-building programmes. Infrastructure development (Years 2-4) involves scaling laboratory manufacturing capabilities, establishing vaccine testing facilities, and launching pilot production programs. The scale-up phase (Years 4-6) transitions to commercial production of EPI vaccines, regulatory approvals, and distribution network establishment. Finally, the optimization phase (Year 6+) expands manufacturing capabilities, develops advanced biologics production, and positions Pakistan as a regional pharmaceutical hub. Financial innovation will be crucial. Blended financing models combining public funding, private investment, and support from institutions like the Islamic Development Bank can mobilise the substantial capital required for drug substance manufacturing facilities. The initial investment may be significant, but the long-term savings and export potential far outweigh the costs. The economic and strategic imperative The benefits extend far beyond health security. A robust domestic vaccine industry could create over 5,000 jobs and reduce import dependency by 50 percent. More importantly, it would establish Pakistan as a regional pharmaceutical hub with significant export potential to neighboring countries and the broader Islamic world. The Covid-19 pandemic demonstrated the critical importance of pharmaceutical self-reliance. Nations with domestic production capabilities could respond rapidly to their populations' needs, while others waited months for external supplies. This lesson cannot be ignored as we face an uncertain global health landscape. The time for action is now Pakistan's demographic dividend — with 65 percent of the population under 30 — represents an unprecedented opportunity to build a knowledge-based pharmaceutical sector. However, this window will not remain open indefinitely. The GAVI deadline of 2031 provides a clear timeline for action, but preparation must begin immediately. The success of this transformation depends on political will, sustained investment, and most importantly, recognition that vaccine self-sufficiency is not a luxury but a national security imperative. Countries that fail to develop domestic pharmaceutical capabilities will remain perpetually vulnerable to supply disruptions, price volatility, and foreign policy pressures. A call to national action The establishment of National and Provincial Coordination Committees bringing together leaders from academia, industry, and regulatory agencies represents the essential first step. This must be followed by a comprehensive assessment of current capabilities, development of a detailed national vaccine strategy, and launch of pilot programmes for immediate impact. Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we need now is the collective will to transform this potential into reality. The health and prosperity of future generations depend on the decisions we make today. The choice is clear: remain dependent on the goodwill of international donors or invest in building a self-reliant pharmaceutical sector that serves not only Pakistan's needs but positions the nation as a leader in global health innovation. The Triple Helix approach offers a proven pathway to pharmaceutical independence-we must have the courage to take it. Copyright Business Recorder, 2025
Business Recorder
4 days ago
- Business Recorder
Qatar urged to upgrade Pakistani surgeons
ISLAMABAD: Pakistan has requested Qatar government to upgrade Pakistani surgeons from category three to category one enabling them to bypass appearing in tests. The request was formerly forwarded by the Federal Minister National Health Services and Regulations Syed Mustafa Kamal's recent visit to Qatar where he met with Qatar' s Health Minister Mansoor bin Ibrahim. The Qatari government assured the minister to seriously consider the request which is a longstanding demand of Pakistani doctors. Meanwhile, Kamal on Tuesday chaired a high level review meeting on polio eradication which was attended by key stakeholders, including the Prime Minister's Focal Person for Polio Eradication, Ayesha Raza Farooq, the Special Secretary Health, Additional Secretary Health, the National Polio Coordinator, as well as representatives from WHO, UNICEF, and provincial health authorities. During the meeting, a comprehensive review of the recent nationwide polio vaccination drive was presented. Over 45 million children were successfully administered the polio vaccine drops. National and provincial coordinators shared detailed updates on the ongoing polio eradication efforts, highlighting progress as well as obstacles. Kamal emphasized that protecting children from polio is a collective national responsibility that requires urgent and sustained efforts from all segments of society. He urged parents to proactively seek out polio workers and ensure the immunization of their children, reminding that safeguarding children's health is a matter of accountability both in this life and the hereafter. The Minister highlighted that while cancer treatment is possible, polio remains an incurable disease, reinforcing the critical need to eliminate the virus through effective vaccination campaigns. He called for a significant policy shift to enhance campaign effectiveness and stressed the importance of unity and societal participation in this national mission. "Only two countries in the world still face the threat of polio," Mustafa Kamal stated, noting ongoing extensive campaigns in Afghanistan, effectively supported by the Taliban government. He expressed his hope for simultaneous polio-free status for both Pakistan and Afghanistan. He concluded by motivating the nation to overcome this challenge, stating, 'If we can defeat India as one nation, we can certainly defeat polio. If Palestine remains polio-free despite war, then what are we waiting for?' The Federal Health Ministry reaffirmed its commitment to intensifying polio eradication efforts to ensure a polio-free Pakistan in the near future. Copyright Business Recorder, 2025
Express Tribune
6 days ago
- Express Tribune
Survivors of terrorism lack access to counselling
Located just 45 kilometers from the Afghan border, Peshawar has been in the grip of terrorism since the last 15 to 20 years, with thousands of people losing their lives and livelihoods to the war on terror. However, not a single rehabilitation center could be built in Khyber-Pakhtunkhwa (K-P) to help victims of terrorism and their families to recover from their trauma. In 2009, Yasir Khan lost six members of his family in the horrific bomb blast in Peshawar's Pipal Mandi. "More than 15 years have passed since the incident, but even today, when a terrorist incident occurs, my mind goes into shock again for a few moments. Perhaps the trauma of that incident has been buried deep within me. About 150 people were killed in the blast while about 250 were injured. The survivors are suffering from post-traumatic stress, but they have not been able to access psychological help," said Khan. Likewise, in 2014, Arif Aqeel, a school teacher was badly injured in two suicide attacks at the All-Saints Church in Peshawar. Hailing from the Christian community, Arif lost one of his legs and a large chunk of his memory due to severe head injuries. Three years later, Arif's wounds could not heal, and he passed away. "First the shock of the explosion and then the death of Arif left a lasting impact on his wife and children. The family has not received counseling till date, due to which they are still suffering from psychological problems," shared Arif's brother-in-law, Augustine Jacob. Similarly, Sir Naeem Gulzar, who was injured in the Peshawar Qissa Khawani blasts twice, shared a poignant narration of what goes on in the mind of a survivor coping with the post-traumatic stress disorder (PTSD). Even though ten years have passed since the tragedy, even today Gulzar is fearful of leaving the house and going to work. "Whenever I hear the sound of a vehicle, rickshaw, or a tyre bursting, I run away, thinking it is an explosion. Despite my efforts, I cannot get rid of the fear in my mind. My family has taken me to a psychiatrist twice, but it has not helped," shared Gulzar. Gulzar's experience is not an isolated case. With the alarming increase in terrorist activity over the past few years, more and more people directly impacted by extremist atrocities are stuck in a cycle of trauma. According to data obtained by The Express Tribune, in 2022, 200 incidents of terrorism were reported in K-P and the tribal areas, while in 2023, 560 incidents of terrorism occurred. In 2022, a total of 83 police officers and 96 soldiers were martyred, while in 2023, 167 police officers and 101 soldiers were killed. These incidents include the Peshawar Police Lines blast, the suicide attack on the Peshawar Kocha Risaldar Mosque and the explosion at a public meeting in Bajaur. In 2023, cases of terrorism witnessed a surge of about 70 per cent in K-P and the tribal areas, while 2024, saw a further 20 per cent increase in such incidents, with 630 incidents reported throughout the year. Talking about the impact of terrorism on the quality of life, Professor Dr Jamil Chitrali, Chairman of the Department of Peace and Conflict Studies at the University of Peshawar, revealed that in the past 20 years, 70,000 to 80,000 people have been killed in terrorist activity in Pakistan, out of which about 60,000 were civilians while 20,000 were personnel from the police, armed forces and other government agencies. "The APS attack, Pipal Mandi and Khyber Bazar blasts were such big tragedies that it seems that people in every street of Peshawar have experiences their trauma. Unfortunately, however, there are only 500 mental health professionals in the country for a population of over 240 million. Until or unless there is a district-level rehab center for victims of terrorism and their families, these people will continue to suffer from despair, depression and psychological problems," implored Dr Chitrali. Dr Uzma Ali, a clinical psychologist, told The Express Tribune that survivors of terrorism required clinical treatment and community support to deal with the post-traumatic stress disorder. "Furthermore, the families of such victims also need counseling. People going through trauma should be supported by family, and relevant institutions such as health, social welfare, and the district administration. These victims should be considered under the Victim Support Program, which could help them cope with their trauma," said Dr Ali.
